ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · IEX Real-Time Price · USD
31.31
-0.08 (-0.24%)
At close: Dec 29, 2023, 4:00 PM
32.00
+0.69 (2.20%)
After-hours: Dec 29, 2023, 7:18 PM EST
ACADIA Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 18 stock analysts, the average 12-month stock price forecast for ACAD stock stock is $32.72, which predicts an increase of 4.50%. The lowest target is $22 and the highest is $42. On average, analysts rate ACAD stock stock as a buy.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACAD stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 5 | 6 |
| Buy | 6 | 4 | 4 | 5 | 5 | 6 |
| Hold | 10 | 9 | 9 | 8 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 20 | 17 | 17 | 18 | 16 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Strong Buy Maintains $35 → $40 | Strong Buy | Maintains | $35 → $40 | +27.75% | Dec 29, 2023 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $31 → $40 | Hold → Buy | Upgrades | $31 → $40 | +27.75% | Dec 19, 2023 |
| Stifel | Stifel | Hold Maintains $25 → $27 | Hold | Maintains | $25 → $27 | -13.77% | Dec 18, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $42 | Buy | Reiterates | $42 | +34.14% | Dec 14, 2023 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $25 | Strong Buy → Hold | Downgrades | $25 | -20.15% | Dec 14, 2023 |
Financial Forecast
Revenue This Year
734.23M
from 517.24M
Increased by 41.95%
Revenue Next Year
974.54M
from 734.23M
Increased by 32.73%
EPS This Year
-0.35
from -1.34
EPS Next Year
0.93
from -0.35
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 763.6M | 1.1B | 1.5B | 2.0B | 3.0B | 2.5B |
| Avg | 734.2M | 974.5M | 1.2B | 1.5B | 1.8B | 1.8B |
| Low | 699.9M | 712.0M | 899.5M | 1.1B | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 47.6% | 55.9% | 55.0% | 66.6% | 102.6% | 40.3% |
| Avg | 42.0% | 32.7% | 22.3% | 22.6% | 21.5% | 0.6% |
| Low | 35.3% | -3.0% | -7.7% | -4.9% | -16.1% | -25.9% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -0.06 | 1.71 | 3.07 | 5.37 | 9.56 | 3.77 |
| Avg | -0.35 | 0.93 | 1.79 | 2.79 | 4.03 | 2.63 |
| Low | -0.40 | 0.03 | 0.79 | 1.47 | 1.56 | 1.50 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | 229.0% | 199.8% | 242.5% | -6.5% |
| Avg | - | - | 92.1% | 55.9% | 44.5% | -34.7% |
| Low | - | - | -14.8% | -17.9% | -44.1% | -62.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.